| Literature DB >> 34155319 |
Jeongseok Kim1,2, Jisup Kim3, Eun Hye Oh1,4, Nam Seok Ham1, Sung Wook Hwang1, Sang Hyoung Park1, Byong Duk Ye1, Jeong-Sik Byeon1, Seung-Jae Myung1, Suk-Kyun Yang1, Seung-Mo Hong3, Dong-Hoon Yang5.
Abstract
Small rectal neuroendocrine tumors (NETs) can be treated using cap-assisted endoscopic mucosal resection (EMR-C), which requires additional effort to apply a dedicated cap and snare. We aimed to evaluate the feasibility of a simpler modified endoscopic mucosal resection (EMR) technique, so-called anchored snare-tip EMR (ASEMR), for the treatment of small rectal NETs, comparing it with EMR-C. We retrospectively evaluated 45 ASEMR and 41 EMR-C procedures attempted on small suspected or established rectal NETs between July 2015 and May 2020. The mean (SD) lesion size was 5.4 (2.2) mm and 5.2 (1.7) mm in the ASEMR and EMR-C groups, respectively (p = 0.558). The en bloc resection rates of suspected or established rectal NETs were 95.6% (43/45) and 100%, respectively (p = 0.271). The rates of histologic complete resection of rectal NETs were 94.1% (32/34) and 88.2% (30/34), respectively (p = 0.673). The mean procedure time was significantly shorter in the ASEMR group than in the EMR-C group (3.12 [1.97] vs. 4.13 [1.59] min, p = 0.024). Delayed bleeding occurred in 6.7% (3/45) and 2.4% (1/41) of patients, respectively (p = 0.618). In conclusion, ASEMR was less time-consuming than EMR-C, and showed similar efficacy and safety profiles. ASEMR is a feasible treatment option for small rectal NETs.Entities:
Year: 2021 PMID: 34155319 PMCID: PMC8217176 DOI: 10.1038/s41598-021-92462-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow chart of patient throughput. NET neuroendocrine tumor, EMR endoscopic mucosal resection, EMR-P EMR with circumferential precutting, ESD endoscopic submucosal dissection, ASEMR anchored snare-tip EMR, EMR-C cap-assisted EMR.
Figure 2Principles of anchored snare-tip endoscopic mucosal resection for a suspected or established rectal neuroendocrine tumor (NET). (a) The snare-tip is anchored into the mucosal incision site on the oral side of the lesion. The anchoring point works as a fulcrum for leverage while the snare-tip is gently pressed toward the direction indicated by the cyan dotted arrow (effort motion). (b) The NET will rise slightly toward the luminal side (red dotted arrow) because of a load motion resulting from the leverage effect. The anchoring should be maintained by pressing the snare-tip toward the mucosal incision site while tightening the snare (continued effort motion toward the direction indicated by the cyan dotted arrow). During snaring, the snare sheath can be pressed downward to ensure en bloc snaring (see the curved tail part of the cyan dotted arrow). (c) A mucosal incision was made on the oral side of the lesion. (d) The snare was anchored while being opened. (e) Anchoring was well maintained until en bloc snaring was completed. (f) En bloc complete resection was possible. (g), (h) The deep safety resection margin was measured after endoscopic resection.
Figure 3A failed case of anchored snare-tip endoscopic resection for an established rectal neuroendocrine tumor (NET). (a) If the anchoring is loosened because of insufficient pressure toward the anchoring point (see the green dotted arrow), the snare will slip at the oral side of the lesion and the rise of the neuroendocrine tumor (NET) secondary to the load motion will not happen. (b) Anchoring was not maintained during snaring, and the snare slipped on the oral side. The yellow arrowhead indicates the mucosal incision site for anchoring. (c) Remnant NET tissue was observed after the anchored snare-tip endoscopic mucosal resection (see the red arrow).
Comparison of ASEMR (n = 45) versus EMR-C (n = 41) for suspected or established rectal NETs.
| ASEMR (n = 45) | EMR-C (n = 41) | p value | |
|---|---|---|---|
| No. of lesions / patients | 45 / 41 | 41 / 38 | |
| Patient characteristics | |||
| Age in years, mean (SD) | 50.9 (10.2) | 43.6 (11.7) | 0.004 |
| Male, n (%) | 24 (58.5%) | 21 (55.3%) | 0.769 |
| Platelet count, × 103/µL, mean (SD) | 254.9 (63.6) | 265.1 (54.6) | 0.450 |
| PT, INR, mean (SD) | 0.99 (0.05) | 1.01 (0.06) | 0.074 |
| aPTT, s, mean (SD) | 27.4 (2.1) | 27.6 (2.4) | 0.691 |
| Antiplatelet medication, n (%) | 1 (2.2%) | 0 | 1.000 |
| Warfarin or DOAC, n (%) | 0 | 0 | NA |
| Lesion characteristics | |||
| Failed endoscopic resection by referring endoscopists, n (%) | 3 (6.7%) | 7 (17.1%) | 0.183 |
| Preprocedural diagnosis, n (%) | 0.280 | ||
| Suspected NET | 25 (55.6%) | 18 (43.9%) | |
| Established NET | 20 (44.4%) | 23 (56.1%) | |
| Endoscopic size, mm, mean (SD), [range] | 5.4 (2.2) [2–13] | 5.2 (1.7) [3–10] | 0.558 |
| Procedure outcomes | |||
| Technical success, n (%) | 43 (95.6%) | 41 (100%) | 0.271 |
| Resection time for successful cases, min, mean (SD) | 2.80 (0.87)a | 4.57 (2.31) | < 0.001 |
| Resection time for overall cases, min, mean (SD) | 3.10 (1.83) | 4.57 (2.31) | 0.002 |
| Final histology, n (%) | 0.401 | ||
| NET | 34 (75.6%) | 34 (82.9%) | |
| No remnant NET or not NET | 11 (24.4%) | 7 (17.1%) | |
| Delayed bleeding, n (%) | 3 (6.7%)b | 1 (2.4%)c | 0.618 |
| Perforation, n (%) | 0 | 0 | NA |
ASEMR anchored snare-tip endoscopic mucosal resection, EMR-C cap-assisted endoscopic mucosal resection, NET neuroendocrine tumor, SD standard deviation, PT prothrombin time, INR international normalized ratio, aPTT activated partial thromboplastin time, DOAC direct oral anticoagulant, NA not applicable.
aTwo failed ASEMR cases were excluded because of direct conversion to ESD during the procedures.
bThree patients experienced delayed bleeding in ASEMR group. One patient with 6 mm-sized rectal NET failed ASEMR attempt due to slippage of snare, and ASEMR was immediately converted to ESD. The other two patients showed scar change and lymphoid polyp in the final histology results, respectively.
cOne patient with 3 mm-sized rectal NET experienced delayed bleeding.
Outcomes of established rectal NETs resected by ASEMR (n = 34) and EMR-C (n = 34).
| ASEMR (n = 34) | EMR-C (n = 34) | p value | |
|---|---|---|---|
| Endoscopic size, mm, mean (SD), [range] | 5.7 (2.3) [2–13] | 5.5 (1.7) [3–10] | 0.672 |
| Pathologic size, mm, mean (SD) [range] | 5.4 (2.5) [1–12] | 4.9 (1.7) [2–10] | 0.402 |
| Grade, n (%) | 0.356 | ||
| Grade 1 | 33 (97.1%) | 30 (88.2%) | |
| Grade 2 | 1 (2.9%) | 4 (11.8%) | |
| Lymphovascular invasion, n (%) | 0 | 0 | NA |
| Resection time, min, mean (SD) | 3.12 (1.97) | 4.13 (1.59) | 0.024 |
| Histologic complete resection, n (%) | 32 (94.1%) | 30 (88.2%) | 0.673 |
| Clear lateral margin, n (%) | 34 (100%) | 32 (94.1%) | 0.357 |
| Clear deep margin, n (%) | 32 (94.1%) | 31 (91.2%) | 0.365 |
| Deep safety resection margin, µm, mean (SD) | 291.8 (347.7) | 259.7 (262.2) | 0.669 |
| Delayed bleeding, n (%) | 1 (2.9%) | 1 (2.9%) | 1.000 |
| Perforation, n (%) | 0 | 0 | NA |
ASEMR anchored snare-tip endoscopic mucosal resection, EMR-C cap-assisted endoscopic mucosal resection, NET neuroendocrine tumor, SD standard deviation, NA not applicable.